BioNeutra Global Corporation (BGACF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
BioNeutra Global Corporation (BGACF) trades at $0.01 with AI Score 41/100 (Grade C). BioNeutra Global Corporation focuses on the production and commercialization of VitaFiber, a low-calorie soluble prebiotic fiber. Market cap: $260,113, Sector: Consumer defensive.
Price live · AI analysis from Mar 16, 2026Analyst Coverage for BGACF: BGACF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates BGACF against Consumer Defensive peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
BGACF: the 1 perspectives are evenly split.
How is this calculated? →BioNeutra Global Corporation (BGACF) Consumer Business Overview
BioNeutra Global Corporation develops, produces, and commercializes VitaFiber, a functional food ingredient targeting the nutraceutical and mainstream food sectors. With a focus on prebiotic fiber, the company serves food manufacturers globally through direct and online retail channels, operating in the competitive packaged foods industry with a negative profit margin.
What Is the Investment Thesis for BGACF?
BioNeutra Global Corporation presents a focused investment opportunity within the functional food ingredients market. The company's reliance on VitaFiber as its primary product exposes it to market concentration risks. With a negative P/E ratio of -0.17 and a negative profit margin of -18.5%, the company's profitability is a concern. However, the gross margin of 36.4% indicates potential for improved efficiency and profitability. Growth catalysts include expanding distribution channels and increasing market penetration in existing and new geographic regions. Investors should closely monitor the company's ability to achieve profitability and manage its operational costs. The company's beta of 0.97 suggests its stock price is slightly less volatile than the market.
Based on FMP financials and quantitative analysis
BGACF Key Highlights
- VitaFiber is the company's lead product, an isomalto-oligosaccharide functional and health food ingredient.
- The company serves markets in Canada, the United States, Europe, Australia, New Zealand, and Southeast Asia.
- BioNeutra distributes VitaFiber through Amazon.com, Shopify.com, and other direct-to-consumer retail channels.
- The company has a gross margin of 36.4%, indicating potential for profitability improvements.
- The company's P/E ratio is -0.17, reflecting current losses.
Who Are BGACF's Competitors?
BGACF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| GPAGF Gruma, S.A.B. de C.V. | $18.50 | +2.21% | $6.31B | 66 |
| PNGAF Pangea Wellness Inc. | $0.37 | +10.51% | $5.54M | 65 |
| ZHYBF Zhong Yuan Bio-Technology Holdings Limited | $2.02 | +0.00% | $35.75M | 64 |
| BOF BranchOut Food Inc. | $4.58 | -4.18% | $70.15M | 61 |
| WESTW Westrock Coffee Company, LLC | $1.92 | +29.73% | $168.42M | 51 |
| PTCXF PT Wilmar Cahaya Indonesia Tbk. | $0.11 | +0.00% | $70.48M | 51 |
| DAR Darling Ingredients Inc. | $57.49 | +1.70% | $9.14B | 51 |
| ASBFF Associated British Foods plc | $25.14 | +0.00% | $17.59B | 51 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are BGACF's Key Strengths?
- Proprietary VitaFiber product with established health benefits.
- Distribution through multiple channels, including online retail.
- Serves a growing market for functional food ingredients.
- Presence in multiple geographic regions.
What Are BGACF's Weaknesses?
- Negative profit margin and P/E ratio.
- Concentration on a single product (VitaFiber).
- Limited brand recognition compared to larger competitors.
- OTC market listing may limit investor access.
What Could Drive BGACF Stock Higher?
- Expansion into new geographic markets, particularly in Asia and South America.
- Strategic partnerships with large food manufacturers to incorporate VitaFiber into their product lines.
- Potential new applications for VitaFiber in various food and beverage products through ongoing R&D.
- Increased online presence and direct-to-consumer sales through targeted marketing campaigns.
- Product diversification with new functional food ingredients beyond VitaFiber.
What Are the Key Risks for BGACF?
- Financial-distress signal — its Altman Z-Score of -1.81 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Competition from larger food ingredient companies with greater resources.
- Changes in consumer preferences and dietary trends impacting demand for VitaFiber.
- Regulatory changes affecting the food industry and the use of VitaFiber.
- Economic downturns impacting consumer spending on functional food ingredients.
- Negative profit margin and P/E ratio indicating financial instability.
What Are the Growth Opportunities for BGACF?
- Expansion into New Geographic Markets: BioNeutra can expand its presence in untapped geographic regions, particularly in Asia and South America, where the demand for functional food ingredients is growing rapidly. This expansion could involve establishing partnerships with local distributors or setting up regional offices. The global functional food market is expected to reach $278 billion by 2030, offering a substantial opportunity for BioNeutra to increase its market share.
- Product Diversification: BioNeutra can diversify its product line by developing new functional food ingredients beyond VitaFiber. This could include exploring other types of prebiotic fibers, as well as ingredients that address other health concerns, such as immune support or weight management. Diversifying the product portfolio would reduce the company's reliance on a single product and broaden its appeal to a wider range of customers. The timeline for new product development would likely be 1-2 years.
- Strategic Partnerships with Food Manufacturers: BioNeutra can forge strategic partnerships with large food manufacturers to incorporate VitaFiber into their product lines. This would provide BioNeutra with access to a larger customer base and increased sales volume. These partnerships could involve co-branding agreements or exclusive supply arrangements. Securing partnerships with major food companies could significantly boost BioNeutra's revenue within the next 2-3 years.
- Increased Online Presence and Direct-to-Consumer Sales: BioNeutra can enhance its online presence and direct-to-consumer sales channels through targeted marketing campaigns and improved e-commerce platforms. This would allow the company to reach a wider audience and build brand awareness. Investing in digital marketing and online sales infrastructure could lead to increased sales and customer loyalty within the next year.
- Research and Development of New Applications for VitaFiber: BioNeutra can invest in research and development to discover new applications for VitaFiber in various food and beverage products. This could involve exploring its use in new categories, such as sports nutrition or infant formula. Developing new applications for VitaFiber would expand its market potential and create new revenue streams. This research could yield results within 2-3 years.
What Opportunities Does BGACF Have?
- Expansion into new geographic markets.
- Product diversification with new functional food ingredients.
- Strategic partnerships with large food manufacturers.
- Increased online presence and direct-to-consumer sales.
What Threats Does BGACF Face?
- Competition from larger food ingredient companies.
- Changes in consumer preferences and dietary trends.
- Regulatory changes affecting the food industry.
- Economic downturns impacting consumer spending.
What Are BGACF's Competitive Advantages?
- Proprietary VitaFiber formulation.
- Established relationships with food manufacturers.
- Direct-to-consumer distribution channels through Amazon.com and Shopify.com.
What Does BGACF Do?
BioNeutra Global Corporation, along with its subsidiaries, specializes in the research, development, production, and commercialization of food ingredients, particularly oligosaccharides, for the nutraceutical, functional, and mainstream food and beverage industries. The company's primary product, VitaFiber, is an isomalto-oligosaccharide recognized as a low-calorie soluble prebiotic fiber that supports human digestive health. BioNeutra serves a diverse clientele, including small and medium enterprises and various food manufacturers, across Canada, the United States, Europe, Australia, New Zealand, and Southeast Asia. VitaFiber is available through multiple channels, including Amazon.com, Shopify.com, and other direct-to-consumer retail platforms. Founded with a focus on innovative food science, BioNeutra has evolved to meet the increasing demand for health-conscious food ingredients. The company is based in Edmonton, Canada, and continues to expand its market reach and product offerings within the functional food sector.
What Products and Services Does BGACF Offer?
- Researches and develops food ingredients for nutraceutical, functional, and mainstream foods.
- Produces VitaFiber, an isomalto-oligosaccharide functional and health food ingredient.
- Offers a low-calorie soluble prebiotic fiber for human digestive health.
- Serves small and medium enterprises in the food manufacturing sector.
- Supplies food manufacturers in Canada, the United States, Europe, Australia, New Zealand, and Southeast Asia.
- Distributes VitaFiber through Amazon.com, Shopify.com, and other direct-to-consumer retail channels.
How Does BGACF Make Money?
- Develops and patents functional food ingredients.
- Manufactures and sells VitaFiber to food manufacturers and consumers.
- Generates revenue through direct sales and online retail channels.
What Industry Does BGACF Operate In?
BioNeutra Global Corporation operates within the packaged foods industry, which is experiencing growth driven by increasing consumer demand for functional and health-oriented food ingredients. The market for prebiotic fibers is expanding as consumers become more aware of the benefits of digestive health. The industry is competitive, with companies like Archer-Daniels-Midland (ASII) and Ingredion (INGR) also active in the space. BioNeutra differentiates itself through its focus on VitaFiber and its direct-to-consumer distribution channels. The global functional food market is projected to reach billions of dollars in the coming years, presenting opportunities for growth.
Who Are BGACF's Key Customers?
- Small and medium enterprises in the food industry.
- Food manufacturers in Canada, the United States, Europe, Australia, New Zealand, and Southeast Asia.
- Consumers seeking functional and health food ingredients.
BioNeutra Global Corporation Financial Trajectory
BioNeutra Global Corporation (BGACF) reported $3.0M in revenue for Q3 2024, reflecting 15.1% growth compared to the prior quarter. The company recorded a net loss of $412K, with diluted EPS of $-0.01. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this micro-cap Consumer Defensive company.
Company Profile
BioNeutra Global Corporation operates in the Packaged Foods industry within the Consumer Defensive sector. It is headquartered in Vancouver, CA. The company is led by CEO Jianhua Zhu. BGACF has traded publicly since 2021.
How BioNeutra Global Corporation Is Valued
BioNeutra Global Corporation carries a market capitalization of 260K, placing it in the micro-cap category. Relative to its peer group, BGACF's quantitative score of 41/100 is below the peer average of 61/100.
ROE 42%Key Financial Metrics
Return on equity for BioNeutra Global Corporation stands at 42.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -13.4%, showing how much profit it generates from its asset base. A current ratio of 0.47 means current liabilities exceed short-term assets, a liquidity point worth watching.
F-Score 2/9Financial Health
BioNeutra Global Corporation's Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -1.81 places it in the distress zone, a signal of elevated financial risk.
BGACF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Proprietary VitaFiber product with established health benefits.
- Distribution through multiple channels, including online retail.
- Serves a growing market for functional food ingredients.
- Presence in multiple geographic regions.
Bear Case
- Negative profit margin and P/E ratio.
- Concentration on a single product (VitaFiber).
- Limited brand recognition compared to larger competitors.
- OTC market listing may limit investor access.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2024 | $3M | -$412,000 | -$0.01 |
| Q2 2024 | $3M | -$757,000 | -$0.02 |
| Q1 2024 | $2M | -$833,000 | -$0.02 |
Based on FMP financials and quantitative analysis
BGACF Latest News
No recent news available for BGACF.
BGACF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for BGACF.
Price Targets
Wall Street price target analysis for BGACF.
BGACF MoonshotScore
What does this score mean?
The MoonshotScore rates BGACF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Jianhua Zhu
CEO
Jianhua Zhu is the Chief Executive Officer of BioNeutra Global Corporation. His background includes extensive experience in food science and technology, with a focus on the development and commercialization of functional food ingredients. He has a strong understanding of the nutraceutical and food manufacturing industries, and has been instrumental in driving the growth of BioNeutra's VitaFiber product line. His expertise spans product development, manufacturing, and distribution strategies.
Track Record: Under Jianhua Zhu's leadership, BioNeutra has expanded its market presence in North America, Europe, and Asia. He has overseen the development of VitaFiber and its commercialization through various channels, including online retail and partnerships with food manufacturers. Key milestones include securing patents for VitaFiber and establishing distribution agreements with major retailers. However, the company has yet to achieve sustained profitability.
BGACF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that BioNeutra Global Corporation may not meet the minimum financial or reporting standards required for higher tiers like OTCQX or OTCQB. Companies on this tier may have limited or no financial disclosure, making it difficult for investors to assess their financial health and operational performance. Unlike NYSE or NASDAQ listings, OTC Other stocks often lack the regulatory oversight and transparency that provide investor protection. This tier is often associated with higher risk and greater potential for fraud or manipulation.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases the risk of investing in BGACF.
- Low trading volume and liquidity can lead to price volatility.
- OTC Other tier listing indicates a higher risk of fraud or manipulation.
- Lack of regulatory oversight compared to major exchanges.
- Potential for difficulty in buying or selling shares at desired prices.
- Verify the company's financial statements and audit reports.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Review the company's legal and regulatory filings.
- Monitor trading volume and price volatility.
- Consult with a financial advisor before investing.
- Confirm the legitimacy of the company's operations and assets.
- Established VitaFiber product with health benefits.
- Distribution through Amazon.com and Shopify.com.
- Presence in multiple geographic regions.
- Patents related to VitaFiber formulation.
- Serves food manufacturers in multiple countries.
What Investors Ask About BioNeutra Global Corporation (BGACF) — Consumer Defensive
What does BioNeutra Global Corporation do?
BioNeutra Global Corporation specializes in the development, production, and commercialization of functional food ingredients, with a primary focus on VitaFiber. VitaFiber is an isomalto-oligosaccharide recognized as a low-calorie soluble prebiotic fiber that supports human digestive health. The company serves small and medium enterprises and various food manufacturers across Canada, the United States, Europe, Australia, New Zealand, and Southeast Asia. BioNeutra distributes VitaFiber through multiple channels, including Amazon.com, Shopify.com, and other direct-to-consumer retail platforms. The company aims to meet the increasing demand for health-conscious food ingredients.
What do analysts say about BGACF stock?
As of 2026-03-16, there is no available analyst coverage for BioNeutra Global Corporation (BGACF). The company trades on the OTC market, which typically has less analyst coverage compared to major exchanges like the NYSE or NASDAQ. Investors should conduct their own due diligence and consider the company's financial performance, growth prospects, and risk factors before making any investment decisions. The company's negative P/E ratio and profit margin should be carefully evaluated.
What are the main risks for BGACF?
The main risks for BioNeutra Global Corporation include its reliance on a single product (VitaFiber), competition from larger food ingredient companies, and the potential for changes in consumer preferences and dietary trends. The company's negative profit margin and P/E ratio also pose financial risks. Additionally, as an OTC-listed company, BGACF faces risks related to limited liquidity, regulatory oversight, and financial disclosure. Investors should carefully consider these risks before investing in BGACF.
What is BioNeutra Global Corporation's geographic revenue mix?
Specific details regarding BioNeutra Global Corporation's geographic revenue mix are not available. However, the company serves markets in Canada, the United States, Europe, Australia, New Zealand, and Southeast Asia. Investors should seek further information on the company's revenue breakdown by region to assess its international growth rates and exposure to emerging markets. This information is crucial for understanding the company's geographic diversification and risk profile.
How does BioNeutra Global Corporation compete with larger packaged food companies?
BioNeutra Global Corporation competes with larger packaged food companies by focusing on its proprietary VitaFiber product and its direct-to-consumer distribution channels. While larger companies may have greater resources and brand recognition, BioNeutra differentiates itself through its specialization in functional food ingredients and its ability to reach consumers directly through online platforms. The company also focuses on building relationships with small and medium enterprises in the food manufacturing sector, providing a niche market for its products.
What are the key factors to evaluate for BGACF?
BioNeutra Global Corporation (BGACF) holds an AI score of 41/100 (low). Not financial advice.
How frequently does BGACF data refresh on this page?
BGACF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven BGACF's recent stock price performance?
BioNeutra Global Corporation (BGACF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary VitaFiber product with established health benefits. See the News tab for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- OTC data may be less reliable than major exchange data.
- Financial data is limited.